Locked-in syndrome

From WikiMD's WELLNESSPEDIA

Locked-in syndrome
CerebellumArteries.svg
Locked-in syndrome can be caused by a stroke
at the level of the basilar artery
denying blood to the pons, among other causes.
Synonyms Cerebromedullospinal disconnection,
ventral pontine syndrome


Specialty Neurology, Psychiatry
















Locked-in syndrome (LIS), also known colloquially as pseudocoma, is a neurological condition characterized by complete paralysis of nearly all voluntary muscles except for those controlling vertical eye movements and blinking. Despite this physical immobility, individuals with LIS remain conscious and cognitively intact, capable of communication via controlled eye movements. Electroencephalography (EEG) results typically appear normal in LIS patients. An even more severe form, termed total locked-in syndrome or completely locked-in state (CLIS), includes paralysis of the eye muscles. The term was first proposed by Fred Plum and Jerome Posner in 1966.

Signs and Symptoms[edit]

In locked-in syndrome, individuals are fully conscious and aware but unable to move or speak due to near-complete paralysis of voluntary muscles. The most commonly preserved voluntary control is over eye movement and blinking, allowing individuals to communicate.

Causes[edit]

Locked-in syndrome typically results from damage to specific portions of the lower brain and brainstem, without affecting the upper brain. Most commonly, it is caused by a stroke or lesions affecting the pons, a part of the brainstem that contains nerve fibers responsible for motor control.

Diagnosis[edit]

Diagnosis of locked-in syndrome involves clinical evaluation, neuroimaging, and electrophysiological studies. It is important to distinguish LIS from other conditions with similar presentations such as coma, vegetative state, or pseudocoma.

Treatment[edit]

There is currently no cure for locked-in syndrome. Treatment primarily focuses on supportive care, rehabilitative therapies, and methods to improve communication. Advanced technologies, such as eye-tracking devices and specialized computer software, can significantly enhance the ability of LIS individuals to interact with their environment.

Prognosis[edit]

The prognosis for individuals with locked-in syndrome can vary significantly. While it is generally considered a stable condition, with proper medical care, individuals can potentially live for several decades. Quality of life can be greatly improved with access to adaptive equipment and supportive care.

Research[edit]

Research into locked-in syndrome is ongoing, with efforts focused on deepening our understanding of the condition and exploring potential therapeutic interventions. Studies encompass a wide range of fields, from basic neuroscience to advanced assistive technology.





Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.